Expanding vaccine efficacy estimation with dynamic models fitted to cross-sectional prevalence data post-licensure.

[1]  M. Gomes,et al.  How direct competition shapes coexistence and vaccine effects in multi-strain pathogen systems. , 2016, Journal of theoretical biology.

[2]  Niel Hens,et al.  Estimating dynamic transmission model parameters for seasonal influenza by fitting to age and season-specific influenza-like illness incidence. , 2015, Epidemics.

[3]  Dao Nguyen,et al.  Statistical Inference for Partially Observed Markov Processes via the R Package pomp , 2015, 1509.00503.

[4]  M. Lipsitch,et al.  Carriage burden, multiple colonization and antibiotic pressure promote emergence of resistant vaccine escape pneumococci , 2015, Philosophical Transactions of the Royal Society B: Biological Sciences.

[5]  Paul S. Wikramaratna,et al.  Five challenges in modelling interacting strain dynamics. , 2015, Epidemics.

[6]  S. Weiss,et al.  Impact of bivalent human papillomavirus (HPV) vaccination upon the risk of acquisition of other HPV types , 2015 .

[7]  N. Low,et al.  Timing of bacterial carriage sampling in vaccine trials: a modelling study. , 2014, Epidemics.

[8]  N. Andrews,et al.  Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study. , 2014, The Lancet. Infectious diseases.

[9]  R. Andrews,et al.  An evaluation of the indirect cohort method to estimate the effectiveness of the pneumococcal polysaccharide vaccine , 2014 .

[10]  David C Whiteman,et al.  Effectiveness of quadrivalent human papillomavirus vaccine for the prevention of cervical abnormalities: case-control study nested within a population based screening programme in Australia , 2014, BMJ : British Medical Journal.

[11]  M. Lipsitch,et al.  A Missing Dimension in Measures of Vaccination Impacts , 2014, PLoS pathogens.

[12]  R. D. del Ángel,et al.  Dengue Vaccines: Strongly Sought but Not a Reality Just Yet , 2013, PLoS pathogens.

[13]  D. Cummings,et al.  Challenges in the Interpretation of Dengue Vaccine Trial Results , 2013, PLoS neglected tropical diseases.

[14]  Michiel van Boven,et al.  Estimation of Vaccine Efficacy and Critical Vaccination Coverage in Partially Observed Outbreaks , 2013, PLoS Comput. Biol..

[15]  Dirk Husmeier,et al.  ODE parameter inference using adaptive gradient matching with Gaussian processes , 2013, AISTATS.

[16]  B. Cowling,et al.  How Is Vaccine Effectiveness Scaled by the Transmission Dynamics of Interacting Pathogen Strains with Cross-Protective Immunity? , 2012, PloS one.

[17]  Saravudh Suvannadabba,et al.  Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial , 2012, The Lancet.

[18]  A. Galvani,et al.  Distinguishing vaccine efficacy and effectiveness. , 2012, Vaccine.

[19]  A. Galvani,et al.  Reevaluation of epidemiological data demonstrates that it is consistent with cross-immunity among human papillomavirus types. , 2012, The Journal of infectious diseases.

[20]  M. Lipsitch,et al.  Serotype replacement in disease after pneumococcal vaccination , 2011, The Lancet.

[21]  N. Andrews,et al.  Using the Indirect Cohort Design to Estimate the Effectiveness of the Seven Valent Pneumococcal Conjugate Vaccine in England and Wales , 2011, PloS one.

[22]  Pedro Alonso,et al.  First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children. , 2011, The New England journal of medicine.

[23]  M. Jit,et al.  7-Valent Pneumococcal Conjugate Vaccination in England and Wales: Is It Still Beneficial Despite High Levels of Serotype Replacement? , 2011, PloS one.

[24]  Pejman Rohani,et al.  Statistical Inference for Multi-Pathogen Systems , 2011, PLoS Comput. Biol..

[25]  M. Girolami,et al.  Riemann manifold Langevin and Hamiltonian Monte Carlo methods , 2011, Journal of the Royal Statistical Society: Series B (Statistical Methodology).

[26]  Marc Lipsitch,et al.  What is the mechanism for persistent coexistence of drug-susceptible and drug-resistant strains of Streptococcus pneumoniae? , 2009, Journal of The Royal Society Interface.

[27]  Claudio J. Struchiner,et al.  Design and Analysis of Vaccine Studies , 2009 .

[28]  K. Auranen,et al.  Estimation of vaccine efficacy against acquisition of pneumococcal carriage. , 2009, Vaccine.

[29]  Luís M A Bettencourt,et al.  The estimation of the effective reproductive number from disease outbreak data. , 2009, Mathematical biosciences and engineering : MBE.

[30]  Marc Lipsitch,et al.  No coexistence for free: neutral null models for multistrain pathogens. , 2009, Epidemics.

[31]  Neil D. Lawrence,et al.  Accelerating Bayesian Inference over Nonlinear Differential Equations with Gaussian Processes , 2008, NIPS.

[32]  B. Bolker,et al.  Vaccine-induced pathogen strain replacement: what are the mechanisms? , 2008, Journal of The Royal Society Interface.

[33]  E. Dasbach,et al.  Cost-effectiveness of quadrivalent human papillomavirus (HPV) vaccination in Mexico: a transmission dynamic model-based evaluation. , 2007, Vaccine.

[34]  Heikki Haario,et al.  DRAM: Efficient adaptive MCMC , 2006, Stat. Comput..

[35]  E. C. Holmes,et al.  Cross-protective immunity can account for the alternating epidemic pattern of dengue virus serotypes circulating in Bangkok , 2006, Proceedings of the National Academy of Sciences.

[36]  Pejman Rohani,et al.  Ecological and immunological determinants of dengue epidemics. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[37]  M. Halloran.  Overview of Vaccine Field Studies: Types of Effects and Designs , 2006, Journal of biopharmaceutical statistics.

[38]  A. Galvani,et al.  Vaccination against multiple HPV types. , 2005, Mathematical biosciences.

[39]  M. Keeling.  Models of foot-and-mouth disease , 2005, Proceedings of the Royal Society B: Biological Sciences.

[40]  D B Richardson,et al.  An incidence density sampling program for nested case-control analyses , 2004, Occupational and Environmental Medicine.

[41]  Graham F Medley,et al.  Infection, reinfection, and vaccination under suboptimal immune protection: epidemiological perspectives. , 2004, Journal of theoretical biology.

[42]  R. Rappuoli,et al.  NadA, a Novel Vaccine Candidate of Neisseria meningitidis , 2002, The Journal of experimental medicine.

[43]  O. Diekmann,et al.  Mathematical Epidemiology of Infectious Diseases: Model Building, Analysis and Interpretation , 2000 .

[44]  E. Lewis,et al.  Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children , 2000, The Pediatric infectious disease journal.

[45]  A. R. Gallant,et al.  Noise and Nonlinearity in Measles Epidemics: Combining Mechanistic and Statistical Approaches to Population Modeling , 1998, The American Naturalist.

[46]  D Kriebel,et al.  Prevalence odds ratio or prevalence ratio in the analysis of cross sectional data: what is to be done? , 1998, Occupational and environmental medicine.

[47]  M. Lipsitch,et al.  Vaccination against colonizing bacteria with multiple serotypes. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[48]  U. Strömberg,et al.  Prevalence odds ratio v prevalence ratio. , 1994, Occupational and environmental medicine.

[49]  P. Kaye.  Infectious diseases of humans: Dynamics and control , 1993 .

[50]  M. Halloran,et al.  Measures of the effects of vaccination in a randomly mixing population. , 1991, International journal of epidemiology.

[51]  M E Halloran,et al.  Direct and indirect effects in vaccine efficacy and effectiveness. , 1991, American journal of epidemiology.

[52]  S Greenland,et al.  Interpretation and choice of effect measures in epidemiologic analyses. , 1987, American journal of epidemiology.

[53]  M. Hernán,et al.  Estimating the per-exposure effect of infectious disease interventions. , 2014, Epidemiology.

[54]  J. Stockman.  First Results of Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Children , 2013 .

[55]  Miguel A Hernán,et al.  The hazards of hazard ratios. , 2010, Epidemiology.